Search Results - "Burkhart, R A"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Patient‐derived organoid models help define personalized management of gastrointestinal cancer by Aberle, M. R., Burkhart, R. A., Tiriac, H., Olde Damink, S. W. M., Dejong, C. H. C., Tuveson, D. A., van Dam, R. M.

    Published in British journal of surgery (01-01-2018)
    “…Background The prognosis of patients with different gastrointestinal cancers varies widely. Despite advances in treatment strategies, such as extensive…”
    Get full text
    Journal Article
  2. 2

    Targeting cell cycle and hormone receptor pathways in cancer by Comstock, C E S, Augello, M A, Goodwin, J F, de Leeuw, R, Schiewer, M J, Ostrander, W F, Burkhart, R A, McClendon, A K, McCue, P A, Trabulsi, E J, Lallas, C D, Gomella, L G, Centenera, M M, Brody, J R, Butler, L M, Tilley, W D, Knudsen, K E

    Published in Oncogene (28-11-2013)
    “…The cyclin/cyclin-dependent kinase (CDK)/retinoblastoma (RB)-axis is a critical modulator of cell cycle entry and is aberrant in many human cancers. New nodes…”
    Get full text
    Journal Article
  3. 3

    Dynamics of Serum CA19-9 in Patients Undergoing Pancreatic Cancer Resection by van Oosten, A.F., Groot, V.P., Dorland, G., Burkhart, Richard A., Wolfgang, C.L., van Santvoort, H.C., He, J., Molenaar, I.Q, Daamen, L.A.

    Published in Annals of surgery (01-03-2024)
    “…Carbohydrate antigen (CA) 19-9 is an established perioperative prognostic biomarker for pancreatic ductal adenocarcinoma (PDAC). However, it is unclear how…”
    Get full text
    Journal Article
  4. 4